The University of Paris is a multidisciplinary university devoted to Health, Science and Society and Humanities in Education and one of the most renowned research clusters in France. It attracts more than 64,000 students including 3,000 PhD students gathered in 21 Research and Training Departments and more than 7,250 researchers and lecturer-researchers gathered in 142 laboratories. Research covers a very wide range in the field of humanities and societies, health, sciences and environment. Chemistry, Mathematics and computer sciences are also represented and placed at the interface with biomedical sciences, thus bringing the necessary fundamental input to assess and modell human activities. The spectrum of human phenomena addressed by research at University of Paris is broad, ranging from reproductive and early development of the embryo to the building-up of human psyche and its connections with family and social environment, including the rules and conventions governing collective life and individual rights.
For more information go to www.u-paris.fr.
The Institute for Radiological Protection and Nuclear Safety (IRSN) is a public organization placed under the joint authority of the French Ministries of the Environment, Health, Research, Industry and Defence. Serving public authorities, IRSN is a body performing research and providing expert assessments into nuclear and radiological risks. It covers the radiological protection of humans, the protection of the environment, the emergency response to radiological and nuclear events, the safety of nuclear reactors, the safety of plants, laboratories, radioactive material transport and waste, the prevention of major accidents in nuclear power plants, as well as the nuclear defence expertise. IRSN has a strong experience in low-dose and high-dose risk research and has implemented transversal activities in dosimetry (external, internal, biological) and epidemiology (follow-up of cohorts of people exposed to environmental, mining, nuclear, and medical exposures).
For more information go to www.irsn.fr.
With its innovations, the Institute of Research and Technology (IRT) b<>com is taking part in the European digital transformation. Its 230 researchers develop tools, products, and services that make everyday life easier. They focus on two fields of research: Hypermedia (ultra-high definition images, 3D sound, smart content, virtual and augmented reality) and more agile ultra-high speed networks (cloud, cybersecurity, ultra-high speed mobile, network resilience, Internet of Things). Of the many fields of application for these technologies, e-health has allowed b<>com to participate in the digital revolution going on in medicine. Founded in 2012 through a public/private partnership, the IRT gathers the best experts from industry and academia at its campus in Rennes, and at its sites in Paris, Lannion and Brest. b<>com is certified ISO 9001 and ISO 13485.
For more information go to www.b-com.com.
The French National Institute of Health and Medical Research (INSERM) is a public scientific and technological institute which operates under the joint authority of the French Ministry of Health and French Ministry of Research. As the only French public research institute to focus entirely on human health, INSERM has the responsibility for the strategic, scientific and operational coordination of biomedical research. Scientific monitoring and expertise are also part of the Institute’s official missions. INSERM has forged close partnerships with other public and private research establishments as well as hospitals to fulfil its missions.
INSERM will contribute to MEDIRAD through two of its laboratories, namely the Cancer Research Center of Toulouse (CRCT), located in Toulouse, and the Laboratoire de Traitement du Signal et de l’Image (LTSI), located in Rennes.
For more information go to www.inserm.fr.
By joining forces, the Claudius Regaud Institute (ICR) and the oncology departments of Toulouse University Hospital Center (CHU) initiated the creation of IUCT, grouping together skills and means to offer a complete and innovative range of public care on three sites: IUCT Purpan, IUCT Rangueil-Larrey and IUCT Oncopole (on the Oncopole Campus). In a second moment they organised a regional care network with 36 partners. The research fields are molecular biology and genetics; tumourous micro-environment; hematology and immunology; experimental therapeutics and dosimetry.
For more information go to www.claudiusregaud.fr.